Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo

Antiviral Research

Volumn 120, Issue , 2015, Pages 126-133

  Zarubaev, V V ^a   Garshinina, A V ^a   Tretiak, T S ^a   Fedorova, V A ^a   Shtro, A A ^a   Sokolova, A S ^b,c   Yarovaya, O I ^b,c   Salakhutdinov, N F ^b,c  

^a Research Institute of Influenza   (Russian Federation)

^b N N VOROZHTSOV NOVOSIBIRSK INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^c NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Antivirals; Cage compounds; Camphor derivatives; Hemagglutinin; Influenza

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; CAMPHECENE; CAMPHOR DERIVATIVE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; RIMANTADINE; UNCLASSIFIED DRUG; CAMPHOR; HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; EC50; FEMALE; HEMAGGLUTINATION INHIBITION TEST; IN VITRO STUDY; INFLUENZA A; INFLUENZA B; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VIRION; VIRUS REPLICATION; VIRUS TITRATION; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; METABOLISM; MICROBIAL SENSITIVITY TEST; ORAL DRUG ADMINISTRATION; ORTHOMYXOVIRIDAE INFECTIONS; PRECLINICAL STUDY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; DRYOBALANOPS; MUS; ORTHOMYXOVIRIDAE;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; CAMPHOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HEMAGGLUTININS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84935836086     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.06.004     Document Type: Article

References (34)

1. Y. Abed, N. Goyette, and G. Boivin Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations Antimicrob. Agents Chemother. 49 2005 556 559
2. S.D. Cady, K. Schmidt-Rohr, J. Wang, C.S. Soto, W.F. Degrado, and M. Hong Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers Nature 463 7281 2010 689 692
3. CDC, 2011. Influenza: The Disease. Centers for Disease Control Prevention. Available: http://www.cdc.gov/flu/about/disease/index.htm.
4. Duque, M.D., Torres, E., Valverde, E., Barniol, M., Guardiola, S., Rey, M., Vázquez, S., 2011. Inhibitors of the M2 channel of influenza A virus. In: Recent Advances in Pharmaceutical Sciences, 35-64 ISBN: 978-81-7895-528-5 Ed. Diego Muñoz-Torrero.
5. Y. Furuse, A. Suzuki, and H. Oshitani Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance Antimicrob. Agents Chemother. 53 2009 4457 4463
6. A. García Martínez, E. Teso Vilar, A. García Fraile, S. de la Moya Cerero, M.E. Rodríguez Herrero, P. Martínez Ruiz, L.R. Subramanian, and A. García Gancedo Synthesis of substituted 1-norbornylamines with antiviral activity J. Med. Chem. 38 1995 4474 4477
7. K. Gavrilov, V. Tsarev, S. Zheglov, A. Korlyukov, M. Antipin, and V. Davankov P,N-bidentate phosphites with a chiral ketimine fragment, their application in enantioselective allylic substitution and comparison with phosphine analogues Synthesis 11 2007 1717 1723
8. J. Geiler, M. Michaelis, P. Sithisarn, and J. Cinatl Jr. Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses Med. Microbiol. Immunol. 200 2011 53 60
9. Gregory, W.A. (E. I. Du Pont de Nnemours & Co), 1971, US 3558704.
10. M.G. Ison Clinical use of approved influenza antivirals: therapy and prophylaxis. Influenza Other Respir Influenza Other Respir. Viruses 3 Suppl. 3 2013 1 7
11. A. Kolocouris, C. Tzitzoglaki, F.B. Johnson, R. Zell, A.K. Wright, T.A. Cross, I. Tietjen, D. Fedida, and D.D. Busath Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A J. Med. Chem. 57 2014 4629 4639
12. K.N. Kozeletskaia, V.M. Blinov, V.A. Karginov, V.V. Burmistrova, A.N. Siniakov, and D.B. Golubev The change in functional activity and primary structure of the M2 protein in variants of the influenza virus resistant to remantadine and deitiforin: common and individual differences from the original strain Mol. Gen. Mikrobiol. Virusol. 6 1989 33 38 (Russian)
13. S.M. Lee, and H.L. Yen Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection Antiviral Res. 96 2012 391 404
14. T. Maeda, and S. Ohnishi Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes FEBS Lett. 122 1980 283 287
15. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1-2 1980 55 63
16. J.S. Oxford Antivirals for the treatment and prevention of epidemic and pandemic influenza Influenza Other Respir. Viruses 1 1 2007 27 34
17. L.A. Perrone, J.K. Plowden, A. García-Sastre, J.M. Katz, and T.M. Tumpey H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice PLoS Pathog. 4 8 2008 e1000115
18. L.H. Pinto, L.J. Holsinger, and R.A. Lamb Influenza virus M2 protein has ion channel activity Cell 69 1992 517 528
19. S.J. Plotch, B. O'Hara, J. Morin, O. Palant, J. LaRocque, J.D. Bloom, S.A. Lang Jr., M.J. DiGrandi, M. Bradley, R. Nilakantan, and Y. Gluzman Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin J. Virol. 73 1999 140 151
20. L.J. Reed, and H. Muench A simple method of estimating fifty percent endpoints Am. J. Hyg. 27 1938 493 497
21. R.J. Russell, P.S. Kerry, D.J. Stevens, D.A. Steinhauer, S.R. Martin, S.J. Gamblin, and J.J. Skehel Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion Proc. Natl. Acad. Sci. U.S.A. 105 2008 17736 17741
22. M. Samson, A. Pizzorno, Y. Abed, and G. Boivin Influenza virus resistance to neuraminidase inhibitors Antiviral Res. 98 2013 174 185
23. C. Scholtissek, G. Quack, H.D. Klenk, and R.G. Webster How to overcome resistance of influenza A viruses against adamantane derivatives Antiviral Res. 37 1998 83 95
24. X. Shen, X. Zhang, and S. Liu Novel hemagglutinin-based influenza virus inhibitors J. Thorac. Dis. 5 Suppl. 2 2013 S149 S159
25. A.S. Sokolova, O.C. Yarovaya, D.V. Korchagina, V.V. Zarubaev, T.S. Tretiak, P.M. Anfimov, O.I. Kiselev, and N.F. Salakhutdinov Camphor-based symmetric diimines as inhibitors of influenza virus reproduction Bioorg. Med. Chem. 22 2014 2141 2148
26. A.S. Sokolova, O.C. Yarovaya, C.A. Shernyukov, C.E. Pokrovsky, C.A. Pokrovsky, V.A. Lavrinenko, V.V. Zarubaev, T.S. Tretiak, P.M. Anfimov, O.I. Kiselev, A.B. Beklemishev, and N.F. Salakhutdinov New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity Bioorg. Med. Chem. 21 2013 6690 6698
27. S.N. Tandura, V.V. Zarubaev, P.M. Anfimov, and O.I. Kiselev Deitiforine, an antiinfluenza chemotherapeutic Antibiot. Khimioter. 58 2013 36 48 (Russian)
28. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-García, A. Lazzarin, G. Carosi, J. Sasadeusz, C. Katlama, J. Montaner, H. Sette Jr., S. Passe, J. De Pamphilis, F. Duff, U.M. Schrenk, D.T. Dieterich APRICOT Study Group Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N. Engl. J. Med. 351 2004 438 450
29. E. Vanderlinden, F. Göktas, Z. Cesur, M. Froeyen, M.L. Reed, C.J. Russell, N. Cesur, and L. Naesens Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin J. Virol. 84 2010 4277 4288
30. J. Wang, C. Ma, V. Balannik, L.H. Pinto, R.A. Lamb, and W.F. Degrado Exploring the requirements for the hydrophobic scaffold and polar amine in inhibitors of M2 from influenza A virus ACS Med. Chem. Lett. 2 2011 307 312
31. J. Wang, C. Ma, G. Fiorin, V. Carnevale, T. Wang, F. Hu, R.A. Lamb, L.H. Pinto, M. Hong, M.L. Klein, and W.F. DeGrado Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2 J. Am. Chem. Soc. 133 2011 12834 12841
32. J. Wang, C. Ma, Y. Wu, R.A. Lamb, L.H. Pinto, and W.F. DeGrado Exploring organosilane amines as potent inhibitors and structural probes of influenza A virus M2 proton channel J. Am. Chem. Soc. 133 2011 13844 13847
33. X. Zhao, Y. Jie, M.R. Rosenberg, J. Wan, S. Zeng, W. Cui, Y. Xiao, Z. Li, Z. Tu, M.G. Casarotto, and W. Hu Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors Antiviral Res. 96 2012 91 99
34. X. Zhao, C. Li, S. Zeng, and W. Hu Discovery of highly potent agents against influenza A virus Eur. J. Med. Chem. 46 2011 52 57